Britannica
Sources used in this answer
- Prescription drug costs - Drug prices
- Prescription drug costs - Pro 2: The government should regulate companies with private interests that result in price gouging, higher drug prices, and limited access to much-needed medicine.
- Prescription drug costs - Con 1: Regulation of drug prices reduces the revenue needed for the research and development of new drugs
- pharmaceutical industry - Drug patents
- Intellectual-property law - Economic and ethical issues
What factors can pharmaceutical companies consider when setting drug prices?
Created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
pharmaceutical industry
A technician withdrawing deep-frozen cells for in vitro culture at a laboratory of a German pharmaceutical company.
Pharmaceutical companies consider several factors when setting drug prices, though they are not required to publicly disclose their specific methodologies. Key considerations include:1
- Research and Development (R&D) Costs: Companies aim to recoup the significant expenses associated with drug discovery and clinical trials, which can cost billions per approved medication.23
- Market Exclusivity: Through patents, companies gain a temporary monopoly that eliminates direct competition, allowing them to set higher prices to recover development costs and generate profits.45
- Market Dynamics: Pricing strategies often account for the presence of competing drugs, the medical uniqueness of the product, and overall market conditions.1
- Corporate Revenue and Growth: Pricing is tied to long-term growth strategies, including the need to fund future research and maintain shareholder value.23
Ethically, it is essential to balance the need for corporate innovation with the moral imperative of ensuring patient access to life-saving medicine. Critics argue that prioritizing profit over affordability—particularly for essential treatments—can lead to price gouging and inequitable health outcomes, raising significant concerns about the social responsibility of the pharmaceutical industry.25